Showing results (221-230 of 1,557) with videos related to
Sort By:
Pageof 156
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1975
[Radioimmunoassay without extraction of L-triiodothyronine in human serum]D Roux, J O Peyrin, A Chambosse, et al.United European Gastroenterology Journal|December 17, 2019
Changes in inflammatory bowel disease patients' perspectives on biosimilars: A follow-up surveyLaurent Peyrin-Biroulet, Sanna Lönnfors, Luisa Avedano, et al.Gastroenterology Clinics of North America|August 12, 2014
Anti-tumor necrosis factor-α monotherapy versus combination therapy with an immunomodulator in IBDParambir S Dulai, Corey A Siegel, Laurent Peyrin-BirouletNature Reviews. Gastroenterology & Hepatology|March 6, 2013
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Laurent Peyrin-Biroulet, Gionata Fiorino, Anthony Buisson, et al.Current Opinion in Pharmacology|November 30, 2020
New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese, et al.Journal of Crohn'S & Colitis|September 11, 2019
Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological StudyDaniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, et al.Immunotherapy|March 13, 2019
Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healingFerdinando D'Amico, Gionata Fiorino, Laurent Peyrin-Biroulet, et al.Journal of Experimental Psychology. Human Perception and Performance|February 7, 2022
It makes sense, so I see it better! Contextual information about the visual environment increases its perceived sharpnessPauline Rossel, Carole Peyrin, Alexia Roux-Sibilon, et al.Analytical Chemistry|July 31, 1998
Sucrose dependence of solute retention on human serum albumin stationary phase: hydrophobic effect and surface tension considerationsE Peyrin, Y C Guillaume, N Morin, et al.Journal of Clinical Medicine|August 12, 2022
Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)Federica Furfaro, Elisa Ragaini, Laurent Peyrin-Biroulet, et al.Pageof 156